v3.25.4
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash Flows from Operating Activities    
Net loss $ (28,292,520) $ (7,635,505)
Adjustments to reconcile net loss to net cash used by operating activities    
Depreciation and amortization 1,355,538 1,328,741
Loss/(gain) on disposal of property and equipment 17,552 (19,133)
Noncash lease expense 941,015 829,119
Goodwill impairment 530,475
Bad debt recovery (9,784) (79,006)
Loss on write-off of related party receivables 216,399 1,409,500
Contract modification - related party 280,545
Share-based compensation 14,236 30,235
Shares issued to pay for services 169,000
Interest expense paid in equity shares 294,977  
Accrued interest on notes payable 1,050,296 1,189,629
Non-cash royalty income (99,001) (53,126)
Amortization of original issue discounts on notes payable 41,667
Loan origination costs 5,000 72,533
Receipt of SOL from staking (12,522)
Non-cash transaction fees 2,755
Unrealized gain on digital assets (150,009)
Loss on excess fair value of warrants 15,088,812 7,255,528
Changes in fair value of warrant liability 10,933,412 (7,840,951)
Changes in operating assets and liabilities net of effects from acquisition of subsidiaries:    
Trade receivables (1,970,245) (1,870,975)
Trade receivables - related party 108,488 (63,462)
Inventory 403,585 1,893,759
Contract assets 11,324 753,994
Prepaid expenses and other current assets (99,745) 733,168
Other assets 219,510 (251,256)
Accounts payable (27,314) (818,733)
Sales tax payable 2,984 37,195
Operating lease liabilities (932,019) (831,536)
Deposits from customers (250,071) 350,981
Accrued expenses 841,348 (690,038)
Contract liabilities 400,851 273,885
Deferred revenue (89,621) (355,699)
Income taxes payable (152,654) (71,285)
Other liabilities 14,526 (226,397)
Net cash provided by/(used in) operating activities 159,315 (3,949,360)
Cash Flows from Investing Activities    
Purchase of property and equipment (1,931,534) (1,297,346)
Proceeds from sale of property and equipment 29,257 63,953
Royalties on related party revenues 40,000 76,000
Purchase of digital assets (998,462)
Investment in MasterpieceVR (100,000) (100,000)
Net cash used by investing activities (2,960,739) (1,257,393)
Cash Flows from Financing Activities    
Proceeds on revolving line of credit 33,144,497 33,071,722
Payments on revolving line of credit (33,093,412) (30,019,244)
Payments on debt (1,095,564) (7,923,914)
Payments on Paycheck Protection Program Loans (50,628) (40,486)
Proceeds on Loan from CEO 200,000
Payments on Loan from CEO (200,000)
Proceeds on bank loans 340,267
Proceeds from notes payable 500,000
Proceeds from warrant exercises 3,438,918
Proceeds from offerings 1,463,550 10,035,292
Expenses on offerings (232,100) (995,333)
Purchases of treasury stock (69,705)
Net cash provided by financing activities 4,075,261 4,398,599
Effect of currency translation (347,188) (121,016)
Net increase/(decrease) in cash, cash equivalents, and restricted cash 926,649 (929,170)
Cash, cash equivalents, and restricted cash at beginning of period 5,420,392 6,349,562
Total cash, cash equivalents, and restricted cash 6,347,041 5,420,392
Balance Sheet Accounts Included in Cash, Cash Equivalents, and Restricted Cash    
Cash and cash equivalents 4,974,303 3,897,511
Restricted cash 1,372,738 1,522,881
Supplemental Disclosure of Cash Flow Information:    
Cash paid during the period for interest 1,018,763 907,307
Cash paid during the period for income taxes, net of refunds 792,628 196,727
Supplemental Schedule of Non-Cash Investing and Financing Activities    
Shares issued to pay for services 169,000
Shares issued to pay notes payable 5,236,027
Financing of fixed asset purchase 28,331
Noncash recognition of new leases 1,011,604 474,874
Noncash dividends 252 236
Series A Warrant Exercises 21,515,769 1,060,113
Series B Warrant Exercises $ 4,409,605

Source

PDF HTML
ZIP XBRL